跳至主要内容
临床试验/NCT03753893
NCT03753893已完成不适用

Prevalence of Ocular Manifestations in Inflammatory Rheumatic Diseases

Lawson Health Research Institute0 个研究点目标入组 5,000 人开始时间: 2013年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,000
主要终点
Prevalence of ocular manifestations of inflammatory rheumatic diseases

研究概览

简要总结

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

详细描述

For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, papilledema, orbital disease, retinal artery/vein occlusion, macular edema, retinitis, chorioretinitis, scleritis, iridocyclitis, choroid hemorrhage, blindness and amaurosis fugax.

These terms were searched in the context of a corresponding inflammatory disease on Medline, Cochrane and Web of Science from their inception (1966, 1991 and 1990 respectively) until the point of study completion.

Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in an inflammatory rheumatic disease. Studies were excluded if they were review articles, case reports where all patients experienced the same ocular comorbidity, if different comorbidities were not grouped independently, and if the study reported on fewer than 20 patients. When the same study cohort was used in more than one analysis, the most recent or largest sample-size study was included. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was used to assess the quality of cohort, case-control, and cross-sectional studies.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Studies were included if they provided numerical data of the prevalence or incidence of ocular manifestations in inflammatory rheumatic disease

排除标准

  • review articles,
  • case reports where all patients experienced the same ocular comorbidity
  • if different comorbidities were not grouped independently
  • if the study reported on fewer than 20 patients

结局指标

主要结局

Prevalence of ocular manifestations of inflammatory rheumatic diseases

时间窗: data is collected once per year up to 2020

Prevalence of ocular manifestations of inflammatory rheumatic diseases

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Janet Pope

Professor of Medicine

Lawson Health Research Institute

相似试验